Literature DB >> 21108207

[Pulmonary embolism in a 30 year-old man with chronic hepatitis C during therapy with pegylated interferon-α and ribavirin].

Waldemar Elikowski1, Małgorzata Małek, Jolanta Kurosz, Iwona Bereszyńska, Andrzej Marszałek, Krystyna Zawilska, Iwona Mozer-Lisewska.   

Abstract

The authors described a case of a 30 year-old man with chronic hepatitis C (G1,S1) complicated by pulmonary embolism (PE), preceded by symptoms of respiratory system infection, which occurred after 6 months of combination therapy with pegylated interferon-α and ribavirin. Right sided nonbacterial thrombotic endocarditis as a source of segmental/subsegmental PE was found. Hemostatic work up showed increased activated protein C resistance, elevated factor VIII activity and fibrinogen concentration as well as hyperhomocysteinaemia (all these disturbances returned to normal 3-6 months later). The patient's clinical status improved during anticoagulation therapy. Antiviral treatment was not continued as virological response was achieved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108207

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  1 in total

1.  Concurrent acute interstitial pneumonia and pulmonary embolism during treatment with peginterferon alpha-2a and ribavirin in a patient with hepatitis C.

Authors:  Hikmet Coban; Mehmet Yahyaoglu; M Bülent Vatan
Journal:  Indian J Pharmacol       Date:  2014 Jul-Aug       Impact factor: 1.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.